According to new research presented at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), people at high risk of having a stroke or heart attack in the next decade who contract COVID-19 are nearly three times more likely to be hospitalised, six times more likely to die from COVID-19.

The Co-Chairs of The Independent Panel for Pandemic Preparedness and Response presented their findings recently in the new report titled Losing Time: End this pandemic and secure the future.

A cheap antidepressant reduced the need for hospitalisation among high-risk adults with Covid-19 in a study hunting for existing drugs that could be repurposed to treat coronavirus.

Laboratory studies show that Merck & Co's (MRK.N) experimental oral COVID-19 antiviral drug, molnupiravir, is likely to be effective against known variants of the coronavirus, including the dominant, highly transmissible Delta, the company said on Wednesday.

The first Covid-19 case was detected on March 8 last year and eventually spread all over the country due to people leaving Dhaka en masse after the March 26 to April 4 “national public holiday” was declared by the government in 2020, according to a recent study.

With the season of major religious festivals across India amidst concerns of a possible third wave of Covid-19, Prime Minister Narendra Modi has stressed the need for constant genome sequencing in order to monitor emergence of new variants of coronavirus.

Researchers at the National Autonomous University of Mexico (UNAM) have created a facemask using silver and copper nanolayers that neutralizes SARS-CoV-2, the virus that causes COVID-19, the university's official gazette said on Thursday.

Two coronavirus vaccines administered using a nasal spray being developed in Thailand are due to start human trials by the end of this year, after promising results in trials involving mice, a government official said on Wednesday.

Antibodies were found in 98 percent people who received full (double) dose of Oxford-AstraZeneca vaccine produced by Serum Institute of India -- called Covishield -- finds a study conducted by Bangabandhu Sheikh Mujib Medical University (BSMMU).

China rejected on Thursday a World Health Organization (WHO) plan for a second phase of an investigation into the origin of the coronavirus, which includes the hypothesis it could have escaped from a Chinese laboratory, a top health official said.